Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Exclusion Criteria

• •adrenal insufficiency (Addison's disease)
• •Scleroderma
• •a fungal infection
• •herpes infection of the eyes
• •osteoporosis
• •a stomach ulcer
• •congestive heart failure
• •high blood pressure
• •recent surgery
• •if you are allergic to pork proteins
• •Do not receive a smallpox vaccine or any "live" vaccine while you are using corticotropin.
• •Patients receiving anti-Tumor Necrosis Factor antibody (e.g. infliximab, adalimumab) in prior six months
• •Uncontrolled diabetes, hypertension, or other contra-indication to increased dosage of glucocorticoids
• •Patients requiring therapy for pulmonary hypertension
• •Females of childbearing potential who are known to be pregnant and/or lactating or who have a positive urine pregnancy test on screening.
• •Current participation in another research drug treatment protocol (patient cannot start another experimental agent until after 90 days)
• •Any other condition that the investigator feels would pose a significant hazard to the patient if Acthar Gel therapy is initiated.